These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
278 related articles for article (PubMed ID: 27725696)
21. Mesothelin virus-like particle immunization controls pancreatic cancer growth through CD8+ T cell induction and reduction in the frequency of CD4+ foxp3+ ICOS- regulatory T cells. Zhang S; Yong LK; Li D; Cubas R; Chen C; Yao Q PLoS One; 2013; 8(7):e68303. PubMed ID: 23874581 [TBL] [Abstract][Full Text] [Related]
22. CD4/CD8 + T cells, DC subsets, Foxp3, and IDO expression are predictive indictors of gastric cancer prognosis. Li F; Sun Y; Huang J; Xu W; Liu J; Yuan Z Cancer Med; 2019 Dec; 8(17):7330-7344. PubMed ID: 31631566 [TBL] [Abstract][Full Text] [Related]
23. Foxp3+ regulatory T cells and the formation of portal vein tumour thrombus in patients with hepatocellular carcinoma. Shen SL; Liang LJ; Peng BG; He Q; Kuang M; Lai JM Can J Surg; 2011 Apr; 54(2):89-94. PubMed ID: 21251418 [TBL] [Abstract][Full Text] [Related]
24. Increased intratumoral regulatory T cells are related to intratumoral macrophages and poor prognosis in hepatocellular carcinoma patients. Zhou J; Ding T; Pan W; Zhu LY; Li L; Zheng L Int J Cancer; 2009 Oct; 125(7):1640-8. PubMed ID: 19569243 [TBL] [Abstract][Full Text] [Related]
25. Regulatory T cells in chronic hepatitis B patients affect the immunopathogenesis of hepatocellular carcinoma by suppressing the anti-tumour immune responses. Zhang HH; Mei MH; Fei R; Liu F; Wang JH; Liao WJ; Qin LL; Wei L; Chen HS J Viral Hepat; 2010 Mar; 17 Suppl 1():34-43. PubMed ID: 20586932 [TBL] [Abstract][Full Text] [Related]
26. PD-L1 Zhou L; Wang J; Lyu SC; Pan LC; Shi XJ; Du GS; He Q Technol Cancer Res Treat; 2021; 20():15330338211045820. PubMed ID: 34605709 [No Abstract] [Full Text] [Related]
27. Peritumoural CCL1 and CCL22 expressing cells in hepatocellular carcinomas shape the tumour immune infiltrate. Wiedemann GM; Röhrle N; Makeschin MC; Fesseler J; Endres S; Mayr D; Anz D Pathology; 2019 Oct; 51(6):586-592. PubMed ID: 31445808 [TBL] [Abstract][Full Text] [Related]
28. Increased frequency of Foxp3+ regulatory T cells in mice with hepatocellular carcinoma. Du Y; Chen X; Huang ZM; Ye XH; Niu Q Asian Pac J Cancer Prev; 2012; 13(8):3815-9. PubMed ID: 23098476 [TBL] [Abstract][Full Text] [Related]
29. Regulatory T cells and their prognostic value in hepatopancreatobiliary tumours. Ozgur HH; Ercetin AP; Eliyatkin N; Seren A; Kupelioglu A; Ortac R; Diniz G; Aktas S Hepatogastroenterology; 2014 Oct; 61(135):1847-51. PubMed ID: 25713876 [TBL] [Abstract][Full Text] [Related]
30. The Prognostic Value of Tumor-infiltrating Lymphocytes in Hepatocellular Carcinoma: a Systematic Review and Meta-analysis. Yao W; He JC; Yang Y; Wang JM; Qian YW; Yang T; Ji L Sci Rep; 2017 Aug; 7(1):7525. PubMed ID: 28790445 [TBL] [Abstract][Full Text] [Related]
31. Expression of Fas/FasL in CD8+ T and CD3+ Foxp3+ Treg cells--relationship with apoptosis of circulating CD8+ T cells in hepatocellular carcinoma patients. Guo CL; Yang XH; Cheng W; Xu Y; Li JB; Sun YX; Bi YM; Zhang L; Wang QC Asian Pac J Cancer Prev; 2014; 15(6):2613-8. PubMed ID: 24761872 [TBL] [Abstract][Full Text] [Related]
32. An increased abundance of tumor-infiltrating regulatory T cells is correlated with the progression and prognosis of pancreatic ductal adenocarcinoma. Tang Y; Xu X; Guo S; Zhang C; Tang Y; Tian Y; Ni B; Lu B; Wang H PLoS One; 2014; 9(3):e91551. PubMed ID: 24637664 [TBL] [Abstract][Full Text] [Related]
33. Regulatory T cell infiltration predicts outcome following resection of colorectal cancer liver metastases. Katz SC; Bamboat ZM; Maker AV; Shia J; Pillarisetty VG; Yopp AC; Hedvat CV; Gonen M; Jarnagin WR; Fong Y; D'Angelica MI; DeMatteo RP Ann Surg Oncol; 2013 Mar; 20(3):946-55. PubMed ID: 23010736 [TBL] [Abstract][Full Text] [Related]
35. Increased prevalence of regulatory T cells in the tumor microenvironment and its correlation with TNM stage of hepatocellular carcinoma. Shen X; Li N; Li H; Zhang T; Wang F; Li Q J Cancer Res Clin Oncol; 2010 Nov; 136(11):1745-54. PubMed ID: 20221638 [TBL] [Abstract][Full Text] [Related]
36. Selective recruitment of regulatory T cell through CCR6-CCL20 in hepatocellular carcinoma fosters tumor progression and predicts poor prognosis. Chen KJ; Lin SZ; Zhou L; Xie HY; Zhou WH; Taki-Eldin A; Zheng SS PLoS One; 2011; 6(9):e24671. PubMed ID: 21935436 [TBL] [Abstract][Full Text] [Related]
37. The ratios of CD8+ T cells to CD4+CD25+ FOXP3+ and FOXP3- T cells correlate with poor clinical outcome in human serous ovarian cancer. Preston CC; Maurer MJ; Oberg AL; Visscher DW; Kalli KR; Hartmann LC; Goode EL; Knutson KL PLoS One; 2013; 8(11):e80063. PubMed ID: 24244610 [TBL] [Abstract][Full Text] [Related]
38. Identification of a FOXP3(+)CD3(+)CD56(+) population with immunosuppressive function in cancer tissues of human hepatocellular carcinoma. Li X; Peng J; Pang Y; Yu S; Yu X; Chen P; Wang W; Han W; Zhang J; Yin Y; Zhang Y Sci Rep; 2015 Oct; 5():14757. PubMed ID: 26437631 [TBL] [Abstract][Full Text] [Related]
39. Association of intra-tumoral infiltrating macrophages and regulatory T cells is an independent prognostic factor in gastric cancer after radical resection. Wang B; Xu D; Yu X; Ding T; Rao H; Zhan Y; Zheng L; Li L Ann Surg Oncol; 2011 Sep; 18(9):2585-93. PubMed ID: 21347781 [TBL] [Abstract][Full Text] [Related]
40. Human hepatocellular carcinoma-infiltrating CD4⁺CD69⁺Foxp3⁻ regulatory T cell suppresses T cell response via membrane-bound TGF-β1. Han Y; Yang Y; Chen Z; Jiang Z; Gu Y; Liu Y; Xu S; Lin C; Pan Z; Zhou W; Cao X J Mol Med (Berl); 2014 May; 92(5):539-50. PubMed ID: 24668348 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]